Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial.
Guimarães HP, de Barros E Silva PGM, Liporace IL, Sampaio RO, Tarasoutchi F, Paixão M, Hoffmann-Filho CR, Patriota R, Leiria TLL, Lamprea D, Precoma DB, Atik FA, Silveira FS, Farias FR, Barreto DO, Almeida AP, Zilli AC, de Souza Neto JD, Cavalcante MA, Figueira FAMS, Junior RA, Moisés VA, Mesas CE, Ardito RV, Kalil PSA, Paiva MSMO, Maldonado JGA, de Lima CEB, D'Oliveira Vieira R, Laranjeira L, Kojima F, Damiani L, Nakagawa RH, Dos Santos JRY, Sampaio BS, Campos VB, Saraiva JFK, Fonseca FH, Pinto IM, Magalhães CC, Ferreira JFM, Lopes RD, Pavanello R, Cavalcanti AB, Berwanger O; RIVER (RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial) Investigators. Guimarães HP, et al. Among authors: almeida ap. Am Heart J. 2021 Jan;231:128-136. doi: 10.1016/j.ahj.2020.10.001. Epub 2020 Oct 10. Am Heart J. 2021. PMID: 33045224
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
Guimarães HP, Lopes RD, de Barros E Silva PGM, Liporace IL, Sampaio RO, Tarasoutchi F, Hoffmann-Filho CR, de Lemos Soares Patriota R, Leiria TLL, Lamprea D, Precoma DB, Atik FA, Silveira FS, Farias FR, Barreto DO, Almeida AP, Zilli AC, de Souza Neto JD, Cavalcante MA, Figueira FAMS, Kojima FCS, Damiani L, Santos RHN, Valeis N, Campos VB, Saraiva JFK, Fonseca FH, Pinto IM, Magalhães CC, Ferreira JFM, Alexander JH, Pavanello R, Cavalcanti AB, Berwanger O; RIVER Trial Investigators. Guimarães HP, et al. Among authors: almeida ap. N Engl J Med. 2020 Nov 26;383(22):2117-2126. doi: 10.1056/NEJMoa2029603. Epub 2020 Nov 14. N Engl J Med. 2020. PMID: 33196155 Clinical Trial.
[Treatment with ganciclovir of congenital cytomegalovirus infections].
Guimarães H, Trindade E, Mateus M, d'Orey C, Almeida A, Martins A, Souto A, Teixeira Santos N. Guimarães H, et al. Arch Pediatr. 1996 Jun;3(6):609-10. doi: 10.1016/0929-693x(96)83238-6. Arch Pediatr. 1996. PMID: 8881312 French. No abstract available.
Leishmania (Sauroleishmania) tarentolae versus pathogenic species: comparative evaluation of protease activity, glycoconjugates, resistance to complement and metabolome composition.
Andrade FFD, Vitório JG, Canuto GAB, Nunes FFC, Rodrigues IA, Almeida APMM, Nascimento FC, Costa AO, Vieira TDS, Silva ACC, André LC, Gontijo CMF, Junqueira C, Toledo JS, Fernandes AP, Soares RP. Andrade FFD, et al. Among authors: almeida apmm. Mem Inst Oswaldo Cruz. 2024 May 20;119:e230243. doi: 10.1590/0074-02760230243. eCollection 2024. Mem Inst Oswaldo Cruz. 2024. PMID: 38775551 Free PMC article.
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis.
Manak M, Gagnon L, Phay-Tran S, Levesque-Damphousse P, Fabie A, Daugan M, Khan ST, Proud P, Hussey B, Knott D, Charlton S, Hallis B, Medigeshi GR, Garg N, Anantharaj A, Raqib R, Sarker P, Alam MM, Rahman M, Murreddu M, Balgobind A, Hofman R, Grappi S, Coluccio R, Calandro P, Montomoli E, Mattiuzzo G, Prior S, Le Duff Y, Page M, Mitchell J, Schwartz LM, Bartsch YC, Azizi A, Bernasconi V; CEPI CLN Study Group. Manak M, et al. Lancet Microbe. 2024 Mar;5(3):e216-e225. doi: 10.1016/S2666-5247(23)00324-5. Epub 2024 Jan 23. Lancet Microbe. 2024. PMID: 38278167 Free article.
Lessons from a Multilaboratorial Task Force for Diagnosis of a Fatal Toxoplasmosis Outbreak in Captive Primates in Brazil.
Schiffler FB, Pereira AHB, Moreira SB, Arruda IF, Moreira FRR, D'arc M, Claro IM, Pissinatti TA, Cavalcante LTF, Miranda TDS, Cosentino MAC, de Oliveira RC, Fernandes J, Assis MRDS, de Oliveira JG, da Silva TAC, Galliez RM, Faffe DS, de Jesus JG, Sobreira Bezerra da Silva M, Bezerra MF, Ferreira Junior ODC, Tanuri A, Castiñeiras TM, Aguiar RS, Faria NR, Almeida AP, Pissinatti A, Sabino EC, Amendoeira MRR, de Lemos ERS, Ubiali DG, Santos AFA. Schiffler FB, et al. Among authors: almeida ap. Microorganisms. 2023 Nov 29;11(12):2888. doi: 10.3390/microorganisms11122888. Microorganisms. 2023. PMID: 38138032 Free PMC article.
Exploring the potential of a new thermotolerant xylanase from Rasamsonia composticola (XylRc): production using agro-residues, biochemical studies, and application to sugarcane bagasse saccharification.
Franco DG, de Almeida AP, Galeano RMS, Vargas IP, Masui DC, Giannesi GC, Ruller R, Zanoelo FF. Franco DG, et al. Among authors: de almeida ap. 3 Biotech. 2024 Jan;14(1):3. doi: 10.1007/s13205-023-03844-0. Epub 2023 Dec 4. 3 Biotech. 2024. PMID: 38058364
306 results